- Seminars on Drug Pricing: Part 3, Aidan Hollis
- Consensus achieved at WIPO Standing Committee on the Law of Patents (SCP) on Future Work Program
- WIPO SCP22: Language on GRULAC proposal to revise 1979 WIPO Model Law for Developing Countries on Inventions
- WIPO SCP22: Informal Non-Paper by Chair on Future Work (30 July 2015, 20:30 version)
- WIPO SCP 22: Written Statement of Knowledge Ecology International on Patents and Health
- SCP22: Australian response to GRULAC proposal to revise 1979 WIPO Model Law for Developing Countries on Inventions
- WIPO SCP22: KEI statement on GRULAC proposal (SCP/22/5)
- SCP22: India’s Intervention on inventive step (SCP/22/3)
- SCP22: Opening statement of the Group of Latin American and Caribbean Countries
- USTR proposals in TPP are in conflict with U.S. Supreme Court decisions on State Sovereign Immunity
WIPO General Assembly 2014: KEI statement on Matters Relating to the Standing Committee on Copyright and Related Rights (SCCR)Submitted by thiru on 24. September 2014 - 9:51
On Wednesday, 24 September 2014, Knowledge Ecology International delivered this intervention on agenda item 15, Matters Relating to the Standing Committee on Copyright and Related Rights (SCCR)
WIPO General Assembly 2014
15. Matters Relating to the Standing Committee on Copyright and Related Rights (SCCR)
Statement of Knowledge Ecology International
WIPO General Assembly 2014: KEI statement on the Report of the Committee on Development and Intellectual Property (CDIP)Submitted by thiru on 24. September 2014 - 9:10
On Wednesday, 24 September 2014, Knowledge Ecology International delivered the following statement at the 2014 WIPO General Assembly on agenda item 13, Report of the Committee on Development and Intellectual Property (CDIP) and Review of the Implementation of the Development Agenda Recommendations.
13. Report of the Committee on Development and Intellectual Property (CDIP) and Review of the Implementation of the Development Agenda Recommendations
Statement of Knowledge Ecology International
Comments of KEI regarding the White House OSTP call for comments on its Strategy for American InnovationSubmitted by James Love on 23. September 2014 - 22:19
Comments of KEI regarding the White House OSTP call for comments on its Strategy for American Innovation
(PDF of comments here)
Attn: Dan Correa, Office of Science and Technology Policy, Eisenhower Executive Office Building, 1650 Pennsylvania Ave NW., Washington, DC 20504.
Re: Strategy for American Innovation
Date: September 23, 2014
This just published by the US FDA:
The U.S. Food and Drug Administration is asking for potential breakthrough ideas on how to find disease-causing organisms in food – especially Salmonella in fresh produce.
The 2014 FDA Food Safety Challenge was developed under the America COMPETES Reauthorization Act of 2010, which grants all federal agencies broad authority to conduct prize competitions to spur innovation, solve tough problems, and advance their core missions. This challenge offers a total prize pool of $500,000.
On Tuesday, 23 September 2014, Knowledge Ecology International (KEI) delivered this opening statement on the occasion of the Fifty-Fourth Series of Meetings of the Assemblies of the Member States of the World Intellectual Property Organization (WIPO).
Thank you Madame Chair for providing Knowledge Ecology International (KEI) the opportunity to speak today.
Today we received news from Nina Mahmud that her father-in-law, Fathi Helmi Aboseda, has passed away in Egypt. Mr. Aboseda was suffering from liver cancer. Earlier this year, Nina Mahmud had contacted Bayer and KEI asking for help in finding affordable copies of sorafenib, a drug for liver and kidney cancer sold by Bayer under the trade name Nexavar, a drug that was extending and improving the quality of his life. The price of Nexavar in Egypt was $900 per week, and Mr. Aboseda had used his entire life savings to buy the drug.
On Monday, 22 September 2014, Kenya, on behalf of the African Group, delivered this opening statement. On normative matters, the African Group expressed the following views regarding the work of the SCCR:
WIPO General Assembly 2014: Opening statement of the United States broaches IGC, broadcasting treaty and copyright L&EsSubmitted by thiru on 22. September 2014 - 14:50
On Monday, 22 September 2014, Ambassador Pamela Hamamoto delivered this opening statement on behalf of the United States at the 2014 WIPO General Assembly.
Ten years on from the launch of the Development Agenda by Argentina and Brazil in 2004, the Obama administration expressed the following views on the Development Agenda:
WIPO General Assembly 2014: Asia Pacific Group charts its position on Broadcast Treaty, Design Law Treaty and copyright L&EsSubmitted by thiru on 22. September 2014 - 4:49
On Monday, 22 September 2014, Bangladesh delivered the following statement on behalf of the Asia Pacific Group. Here below is the Group's position on WIPO's normative work including copyright limitations and exceptions for libraries and archives, copyright limitations and exceptions for educational and research institutions and persons with other disabilities, the proposed Design Law Treaty, the proposed broadcasting treaty and proposed instruments for the protection of genetic resources, traditional knowledge and traditional cultural expressions.
On September 8, 2014, Vice President Joe Biden wrote to Juan Manuel Santos Calderón, the President of Colombia. In the letter, Biden registered a complaint about the regulations in Colombia to register biosimilar drugs. A copy of the letter from Vice President Joe Biden is available here, and includes this quote:
A long standing parlor game for WIPO insiders and observers during the summer of 2014 involved guessing the composition of WIPO's new Senior Management Team (the team of deputy director generals and assistant director generals who form WIPO's cabinet). On 16 September 2014, the WIPO secretariat laid this to rest by revealing the composition of the new WIPO Senior Management Team of deputy director generals and assistant director generals. New faces in the cabinet include: Mr.
On Monday, September 15, 2014, Gilead announced licensing agreements with 7 generic drug manufacturers, for two of its HCV drugs, including sofosbuvir, which is currently the most important HCV drug, and the basis for Gilead’s value to shareholders. KEI's statement from Monday, and links to other NGO comments are here: http://www.keionline.org/node/2082.
KEI welcomes the Gilead HCV licenses, as a step to expand access to treatments. Notes challenges that remainSubmitted by KEI Staff on 15. September 2014 - 6:28
Today Gilead announced it will provide seven generic drug manufacturers licenses to make and sell two drugs that are used in combination to treat the Hepatitis C Virus (HCV) in 91 developing countries.
In 2012, as a member of the Senate Finance Committee, Senator Ron Wyden was a strong advocate for providing the public with access to the TPP negotiating text. Now, as Chairman, the Senator has been silent on the public's right to the text. This is an example of Wyden in 2012. Has his position changed?
Timestamp and notes on Wyden comments on need for transparency in TPP
WIPO General Assembly 2014: Hard Decisions on the Broadcast Treaty and work program on copyright limitations and exceptionsSubmitted by thiru on 3. September 2014 - 7:50
In the piece, WIPO General Assembly 2014: Hard Decisions on the Design Law Treaty and Treaty for Protection of Genetic Resources (22 July 2014), KEI highlighted the hard decisions awaiting the WIPO General Assembly (22 September 2014 to 30 September 2014) with respect to the Design Law Treaty, the imminent revision of the Lisbon Agreement to include geographical indications and WIPO's work to conclude an instrument for the protection of genetic resources, traditional knowledge and folklore.